Dolby Laboratories (NYSE:DLB – Get Free Report) was downgraded by analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a research note issued on Saturday.
DLB has been the subject of several other research reports. Barrington Research decreased their price target on Dolby Laboratories from $95.00 to $90.00 and set an “outperform” rating for the company in a research note on Monday, January 26th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Dolby Laboratories in a research report on Monday, December 29th. Finally, Rosenblatt Securities reiterated a “buy” rating and set a $85.00 price target on shares of Dolby Laboratories in a report on Friday. Three research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $90.75.
Read Our Latest Research Report on Dolby Laboratories
Dolby Laboratories Stock Up 1.8%
Dolby Laboratories (NYSE:DLB – Get Free Report) last issued its quarterly earnings data on Thursday, January 29th. The electronics maker reported $1.06 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.99 by $0.07. The firm had revenue of $346.71 million during the quarter, compared to analysts’ expectations of $341.26 million. Dolby Laboratories had a net margin of 17.97% and a return on equity of 11.49%. Dolby Laboratories’s revenue for the quarter was down 2.8% on a year-over-year basis. During the same period in the prior year, the company posted $1.14 earnings per share. As a group, research analysts predict that Dolby Laboratories will post 2.94 earnings per share for the current fiscal year.
Insiders Place Their Bets
In other news, SVP Shriram Revankar sold 3,000 shares of the firm’s stock in a transaction on Friday, November 21st. The shares were sold at an average price of $65.55, for a total value of $196,650.00. Following the sale, the senior vice president owned 67,435 shares in the company, valued at approximately $4,420,364.25. This trade represents a 4.26% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CEO Kevin J. Yeaman sold 6,751 shares of the business’s stock in a transaction dated Wednesday, December 17th. The stock was sold at an average price of $67.24, for a total transaction of $453,937.24. Following the transaction, the chief executive officer owned 98,377 shares in the company, valued at approximately $6,614,869.48. The trade was a 6.42% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 137,120 shares of company stock valued at $9,184,809 over the last ninety days. 37.93% of the stock is owned by insiders.
Institutional Investors Weigh In On Dolby Laboratories
A number of institutional investors have recently added to or reduced their stakes in the stock. Royal Bank of Canada boosted its position in Dolby Laboratories by 3.5% in the first quarter. Royal Bank of Canada now owns 68,367 shares of the electronics maker’s stock valued at $5,491,000 after buying an additional 2,298 shares in the last quarter. Goldman Sachs Group Inc. increased its holdings in shares of Dolby Laboratories by 218.8% during the first quarter. Goldman Sachs Group Inc. now owns 249,574 shares of the electronics maker’s stock worth $20,043,000 after buying an additional 171,288 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its stake in shares of Dolby Laboratories by 5.6% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 238,216 shares of the electronics maker’s stock valued at $19,131,000 after acquiring an additional 12,598 shares during the last quarter. Focus Partners Wealth bought a new position in shares of Dolby Laboratories in the first quarter valued at approximately $390,000. Finally, Public Employees Retirement System of Ohio boosted its holdings in shares of Dolby Laboratories by 1.3% in the 2nd quarter. Public Employees Retirement System of Ohio now owns 19,629 shares of the electronics maker’s stock worth $1,458,000 after acquiring an additional 248 shares in the last quarter. 58.56% of the stock is owned by institutional investors and hedge funds.
Dolby Laboratories News Roundup
Here are the key news stories impacting Dolby Laboratories this week:
- Positive Sentiment: Company raised FY‑2026 and Q2 guidance well above Street estimates (FY EPS 4.30–4.45 vs. consensus ~3.79; Q2 EPS 1.29–1.44). The stronger outlook is the main catalyst supporting the stock today.
- Positive Sentiment: Dolby announced a quarterly dividend of $0.36 per share (yield ~2.3%), which can attract income-oriented investors and support the share price around the ex‑dividend date.
- Positive Sentiment: Rosenblatt reaffirmed a “Buy” rating with an $85 price target, adding analyst support and upside narrative for investors. Benzinga
- Neutral Sentiment: Q1 results beat consensus on EPS ($1.06 vs. ~$0.99) and revenue (~$346.7M vs. ~341M), indicating operational resilience even as some metrics softened. PR Newswire
- Negative Sentiment: Revenue and EPS were down year-over-year (revenue down ~2.8%), driven by weaker licensing, which triggered an after‑hours selloff after the print and remains a near-term risk. Zacks
- Negative Sentiment: Operational and cash-flow pressures were noted (operating profit and net income declined; temporary negative operating cash flow and higher capex flagged by third‑party summaries), which could weigh on near‑term margins and investor sentiment. Quiver Quant
About Dolby Laboratories
Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.
Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.
Read More
- Five stocks we like better than Dolby Laboratories
- Do not delete, read immediately
- NEW LAW: Congress Approves Setup For Digital Dollar?
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
- A U.S. “birthright” claim worth trillions – activated quietly
- The Crash Has Already Started (Most Just Don’t See It Yet)
Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
